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Boston, Massachusetts 
A 75 year old man with long-standing rheumatic mitral 
stenosis who refused surgical intervention was treated 
with percutaneous balloon valvuloplasty. Prevalvulo-
plasty evaluation revealed a heavily calcified mitral valve, 
a mean transvalvular gradient of 18 mm Hg, a Fick 
cardiac index of 1.7 liters/min per m2, a mitral valve 
area of 0.6 cm2 and 1 + mitral regurgitation. After trans-
septal catheterization and balloon dilation of the inter-
atrial septum with an 8 mm angioplasty balloon, a 25 
mm valvuloplasty balloon was advanced over a guide 
wire across the interatrial septum and positioned across 
the mitral anulus. Subsequent balloon inflation at 3 atm 
pressure resulted in a reduction of the mean mitral valve 
gradient to 12 mm Hg, an increase in cardiac index to 
2.5 liters/min per m2, an increase in mitral valve area 
in 1.4 cm2 and an increase in mitral regurgitation from 
Percutaneous balloon angioplasty is a commonly used tech-
nique in invasive cardiology and to date has been applied 
successfully in the dilation of peripheral arteries (I), renal 
(2) and coronary (3) artery stenoses, hypoplastic and stenotic 
pulmonary arteries (4), aortic coarctations (5) and venous 
obstructions (6). In addition, several investigators have used 
balloon dilation successfully in the treatment of valvular 
stenoses, including congenital pulmonary stenosis (7), con-
genital aortic stenosis (8) and rheumatic mitral stenosis in 
young patients (9). Although balloon valvuloplasty appears 
to be a safe and effective technique in relatively young 
patients, the efficacy of this technique has not been tested 
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1 + to 2 +. Valvuloplasty was well tolerated without 
embolization of clot or valvular debris, and resulted in 
marked clinical improvement with decreased dyspnea 
and increased exercise tolerance. 
Repeat catheterization 2 months after valvuloplasty 
showed further resolution of pulmonary hypertension 
and no evidence of valvular restenosis or worsening mi-
tral regurgitation, but detected a small atrial septal de-
fect with a pulmonary to systemic blood flow ratio of 
1.8. It is concluded that percutaneous valvuloplasty is 
possible in the adult patient with calcific rheumatic mi-
tral stenosis, and may result in a significant improvement 
in valvular function without producing life-threatening 
complications. 
(J Am Coil CardioI1986;7:1410-S) 
adequately in older adult patients with long-standing cal-
cified valvular obstruction. Accordingly, we tested the ap-
plicability of balloon valvuloplasty in a 75 year old patient 
with long-standing rheumatic mitral stenosis. 
Case Report 
Clinical History 
The patient is a 75 year old white man with long-standing 
rheumatic mitral valve disease who was admitted to the Beth 
Israel Hospital with right and left heart failure. Prior medical 
history was notable only for severe chronic obstructive lung 
disease. Twelve months before admission, the patient pre-
sented with mild left heart failure and murmurs of mitral 
stenosis and regurgitation. Echocardiographic studies dem-
onstrated rheumatic mitral stenosis and regurgitation, a di-
lated left atrium (5.8 cm) and findings compatible with right 
ventricular pressure overload and secondary tricuspid re-
gurgitation. The patient was treated with furosemide and 
his condition improved. Eleven months before admission, 
he was admitted with symptomatic episodes of sinus brady-
cardia and complete heart block, ultimately requiring im-
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plantation of a permanent dual chamber (DDD) cardiac 
pacemaker. Four months before admission, he presented 
with chest pain and congestive heart failure. There was no 
evidence of oiyocardial infarction. After treatment with in-
creasing doses of diuretic drugs and the addition of captopril 
to his regimen, there was mild improvement in his symp-
tomatic status. After discharge to an intermediate care fa-
cility, he developed increasing dyspnea, hemoptysis and 
dysphagia. He was subsequently seen in our emergency 
ward and was admitted because of severe right and left heart 
failure. 
Physical examination. The findings at the time of ad-
mission included a blood pressure of 100/60 mm Hg, a heart 
rate of 100 beats/min, a labored respiratory rate of 28/min 
and no temperature elevation. The patient appeared chron-
ically ill with marked wasting and cachexia. The jugular 
venous pressure was elevated to 16 cm H20. Carotid up-
strokes were normal. Lung examination revealed dullness 
to percussion over both lung bases with bilateral rales one-
third to one-half way up. Cardiac auscultation revealed a 
loud first heart sound followed by a grade 2/6 holosystolic 
murmur of mitral regurgitation. The pulmonary component 
of the second heart sound was increased, and there was a 
soft opening snap and a faint diastolic rumble of mitral 
stenosis. There was a soft systolic ejection murmur at the 
lower left sternal border that radiated to the base of the 
heart, but there was no evident aortic insufficiency. Ab-
dominal examination demonstrated an enlarged liver that 
was not tender. There was 4 + pitting edema of both lower 
limbs up to midthigh. Neurologic examination was normal. 
Initial laboratory studies. Complete blood count, platelet 
count, prothrombin time, serum electrolytes, blood urea 
nitrogen, serum creatinine, liver transaminases and bilirubin 
were normal. Chest X-ray films showed an enlarged heart, 
a prominent right heart border and a dilated left atrium; 
there was pulmonary vascular engorgement and a sizable 
right-sided pleural effusion. An electrocardiogram revealed 
a heart rate of 100 beats/min, which was 100% paced in 
the DDD mode. Arterial blood gas determination on 2 li-
ters/min of oxygen included a pH of 7.47, a partial pressure 
of oxygen (Po2) of 74 mm Hg and a partial pressure of 
carbon dioxide (PC02) of 46 mm Hg. 
Cardiac catheterization. After admission, the patient 
underwent diagnostic thoracentesis which demonstrated a 
transudative right pleural effusion. He received intravenous 
furosemide with mild symptomatic improvement in dyspnea 
but persistent hemoptysis. Diagnostic cardiac catheteriza-
tion revealed a mean gradient across the mitral valve during 
diastole of 20 mm Hg, a Fick cardiac index of 1.6 liters/min 
per m2 mm Hg and a calculated mitral valve area of 0.6 
cm2 • Left ventriculography was not performed. Coronary 
angiography demonstrated an occluded right coronary artery 
and aneurysmal dilation of a proximal left anterior descend-
ing coronary artery with a 40% stenosis in its first diagonal 
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branch. During catheterization, a radionuclide ventriculo-
gram was obtained which demonstrated a left ventricular 
ejection fraction of 42% and a right ventricular ejection 
fraction of 14%. The stroke volume ratio was 0.9. 
Surgical evaluation. Despite continued administration 
of large doses of intravenous diuretic drugs, the symptoms 
of dyspnea and hemoptysis did not improve. The patient 
was evaluated by the cardiovascular surgery staff who thought 
that the mitral valve could be replaced but that the expected 
risk of surgical intervention would be high. Mitral valve 
replacement was recommended, but the patient refused. 
Because the patient was severely limited by dyspnea, 
consideration was given to treatment of the mitral stenosis 
by percutaneous balloon valvuloplasty. The patient accepted 
the procedure and informed consent was obtained under a 
protocol approved by the Beth Israel Human Studies Com-
mittee after the potential risks and benefits were explained 
to the patient. 
Balloon Valvuloplasty Procedure 
The patient was brought to the catheterization laboratory 
and his left femoral artery and left and right femoral veins 
were instrumented with 8F Hemokit sheaths (USCI) under 
local anesthesia. Left and right heart catheterization with a 
7F pigtail catheter and 7F balloon flotation catheter were 
subsequently performed from the left groin. During the right 
heart catheterization, a diagnostic oxygen saturation series 
was obtained. After placement of the left and right heart 
catheters, measurements were made of baseline hemody-
namics. The pulmonary capillary wedge position was con-
firmed by aspiration of blood with an oxygen saturation of 
96%. Oxygen consumption was estimated at 125 mIl min 
per m2 because the patient was receiving supplemental ox-
ygen. After the completion of pressure measurements, left 
ventriculography was performed in the routine manner. 
After prevalvuloplasty measurements, a 7F MuIlirts trans-
septal long sheath and dilator (USCI) were advanced from 
the right femoral vein over a guide wire and positioned in 
the superior vena cava. A standard Brockenbrough needle 
was advanced to the tip of the dilator, both the needle and 
dilator were withdrawn to the fossa ovalis of the right atrium 
anG the left atrium was then entered by advancing the needle 
under C-arm fluoroscopic control. Correct needle position 
in the left atrium was confirmed with oximetry, pressure 
measurement and contrast injection, and the sheath and di-
lator were then advanced. The needle and dilator were re-
moved and a 7F balloon-tipped end-hole catheter was ad-
vanced from the sheath to the left atrium. Left heart pressures 
and transvalvular gradients were then measured directly to 
corroborate the previously obtained wedged pressure mea-
surements. The 7F balloon catheter was advanced through 
the mitral and aortic valves to the descending aorta, followed 
by insertion of a 0.038 inch (0.097 cm), 300 cm long Teflon-
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coated exchange guide wire (Cook, Inc.) through the flow-
directed catheter. The sheath and balloon catheter were then 
removed, leaving only the guide wire in place. 
Next, an 8F angioplasty catheter (Mansfield Scientific) 
with an 8 mm balloon was advanced over the guide wire 
to the level of the interatrial septum and used to dilate the 
septum. After removal of this catheter, a 9F balloon dilation 
catheter (Mansfield Scientific) with a 25 mm balloon was 
advanced across the septum through the left atrium and 
positioned across the mitral anulus. Three 15 to 30 second 
balloon inflations with a mixture of saline solution and io-
dinated contrast medium (Angiovist 282) were then per-
formed at 3· atm pressure with continuous monitoring of 
pulmonary artery and systemic arterial pressures. During 
the first two inflations, the balloon was positioried too dis-
tally (that is, in the left ventricular cavity); during the third 
inflation, a waist was seen in the balloon at the level of the 
mitral villve which subsequently disappeared during maxi-
mal inflation at 3 atm. 
Immediately after catheter commissurotomy, all hemo-
dynamic measurements including determinations of trans-
valvular gradient and cardiac output were repeated. Left 
ventriculography was also repeated to assess the degree of 
mitral regurgitation, and a complete right heart oximetry 
series was repeated to look for evidence of a new left to 
right atrial shunt. Two months after valvuloplasty, repeat 
catheterization was performed to reassess hemodynamics. 
Results 
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Postvalvuloplasty data. The patient tolerated mitral valve 
dilatiori well without evidence of embolic phenomena at the 
time of the procedure and in the 6 months after valvulo-
plasty. He continued to receive furosemide and captopril, 
and duriIig the 3 week period after valvuloplasty, diuresis 
resulted in a weight ioss of 18 kg. The patient reported 
significant alleviation of dyspnea and increased exercise 
tolerance and was discharged to his home. 
Table 1 summarizes hemodynamic measurements before 
and after percutaneous mitral valvuloplasty. Major imme-
diate changes produced by the valvuloplasty procedure in-
cluded a decrease iIi mean transvalvular gradient from 18 
to 12 mm Hg, an increase in cardiac index from 1. 7 to 2.5 
liters/min per m2 and an increase in calculated mitral valve 
area from 0.6 to 1.4 cm2 • Right heart oximetry series showed 
no evidence of a significant oxygen step-up before and im-
mediately after valvuloplasty. Serial left ventriculography 
demonstrated a mild increase in mitral regurgitation from 
1 + to 2 + . Figure 1 shows left ventricular and pulmonary 
capillary wedge pressures before and after valvuloplasty. 
Figure 2 shows the valvuloplasty balloon being inflated within 
the mitral valve. 
Follow-up cardiac catheterization. Table 1 summa-
rizes hemodynamic data at the time of catheterization 2 
months after valvuloplasty. Of note, there was no evidence 
Table 1. Hemodynamics Before and After Mitral Valvuloplasty 
Pressures (mm Hg) 
Right atriuin (a/v) 
Meafi 
Right ventricle (s/ed) 
Pulmonary artery (s/ed) 
Mean 
Pulmonary wedge (a/v) 
Mean 
Left atrium (a/v) 
Mean 
Left ventricle (s/ed) 
Systemic artery (s/ed) 
Mean 
He~ rate (beats/min) 
Cardiac output (liters/min) 
Cardiac index (liters/min per m2) 
Oxygen consumption index (mllmin per m2) 
Arteriovenous oxygen difference (mlliiter) 
Systemic vascular resistance (dynes.s-cm - 5) 
Pulmonary vascular resistance (dynes.s-cm - 5) 
Mean mitral valve gradient (mm Hg) 
Mitral valve area (cm2) 
Systemic blood flow (liters/min) 
Pulmonary blood flow (liters/min) 
Puimonary to systemic blood flow ratio 
Before 
Dilation 
17/22 
18 
80/14 
80/45 
58 
-/-
34 
35/43 
34 
113/10 
113/68 
85 
78 paced 
3.3 
1.7 
125* 
73 
1,624 
582 
18 
0.6 
After Dilation 
20127 
20 
68/20 
68/34 
50 
-/27 
23 
25/36 
26 
108115 
108/64 
83 
76 paced 
4.8 
2.5 
125* 
51 
1,050 
450 
12 
1.4 
*Assumed value. a/v = a wave/v wave; sled = systolic/end-diastolic. 
2 Months 
After Dilation 
4/4 
3 
51115 
51119 
29 
12/11 
10 
14/13 
11 
9118 
91/47 
60 
64 paced 
131 
1,060 
147 
6 
1.4 
4.3 
7.7 
1.8 
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Figure 1. Left ventricular (LV) and pUlmonary capillary wedge 
(PCW) pressures before valvuloplasty (A). immediately after val-
vuloplasty (B) and 2 months postvalvuloplasty (el. The mean 
transvalvular gradient is approximately 18 mm Hg before dilation. 
12 mm Hg immediately after dilation and 6 mm Hg 2 months 
later. ECG = electrocardiogram. 
of valvular restenosis with a repeat calculated valve area of 
1.4 cm2 and no change in the amount of mitral regurgitation 
on left ventriculography. Repeat right heart oximetry series, 
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however. demonstrated a significant oxygen step-up with a 
calculated pulmonary to systemic blood flow ratio of 1.8. 
This interatrial shunt was well tolerated as evidenced by a 
marked decrease in right and left heart filling pressures and 
a marked decrease in pulmonary vascular resistance. 
Discussion 
The technique of percutaneous mitral commissurotomy 
through a transseptal approach has been described previ-
ously by Lock et al. (9), who perfonned successful balloon 
valvuloplasty in eight children and young adults (aged 9 to 
23 years) with moderate to severe mitral stenosis. Patients 
with evidence of mitral regurgitation or mitral calcification, 
however. were excluded. This case study complements the 
report of Lock et al. and has documented that in at least 
one patient with long-standing calcific rheumatic mitral ste-
nosis. balloon valvuloplasty may result in significant im-
provement in valvular function without the production of 
severe mitral regurgitation or emboli. 
Theoretic considerations and potential problems. The 
use of a blunt dilating instrument to effect improvement in 
valvular function in rheumatic mitral stenosis has been pre-
viously documented in both closed and open mitral com-
missurotomy (10-15). More recent. Inoue et al. (16) doc-
umented the successful use of a surgically introduced balloon 
catheter to dilate stenotic mitral valves. Because simple 
separation of fused mitral leaflets by blunt pressure results 
in a marked increase in effective orifice area, it follows that 
this pressure might be applied by way of a percutaneously 
introduced balloon catheter without thoracotomy. The the-
oretic risks involved in this technique would include the 
potential complications associated with commissurotomy, 
plus the added risks of the balloon dilation procedure. 
In particular. the risks include: I) creation of a significant 
atrial septal defect secondary to dilation of the interatrial 
septum to allow accommodation of a relatively large val-
vuloplasty balloon; 2) problems arising from the positioning 
of a valvuloplasty balloon across a tightly stenotic mitral 
valve; 3) short-term hemodynamic deterioration during bal-
loon occlusion of the mitral valve orifice; 4) systemic em-
bolization of left atrial thrombus or mitral valve debris; 5) 
creation of severe mitral regurgitation; and 6) mitral reste-
nosis. All of these risks must be added to the usual risks of 
bilateral heart catheterization and transseptal catheteriza-
tion. 
With respect to atrial septal defect creation. it is notable 
that in this case study a small interatrial shunt was detected 
2 months after the procedure. The marked decrease in the 
patient's filling pressures and pulmonary vascular resist-
ance. however. suggest that the deleterious effect of this 
interatrial communication was minimal. This shunt may not 
have been apparent immediately after valvuloplasty because 
of the elevated right atrial pressure at the time of the pro-
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Figure 2. Photograph of the 25 mm val-
vuloplasty balloon being inflated within 
the mitral anulus, 
cedure and the subsequent lack of a pressure gradient across 
the interatrial septum. Acute shunt creation could be par-
ticularly deleterious in patients with long-standing pulmo-
nary hypertension secondary to mitral stenosis, because the 
added volume load on the patient's right ventricle could 
theoretically lead to worsening hemodynamic conse-
quences. Of note, in the previous series of children and 
young adults (9), no significant right to left shunt was de-
tected by oximetry after valvuloplasty. 
Perhaps one of the most worrisome concerns surrounding 
valvuloplasty is the possibility of embolization of clot or 
valvular debris during or after balloon dilation. For this 
reason, when potential valvuloplasty candidates undergo 
echocardiography, special attention should be directed to 
detection of left atrial thrombus that might embolize during 
the valvuloplasty procedure. In such patients, perhaps, any 
percutaneous balloon dilation procedure should be deferred. 
It is notable that other investigators have not observed em-
bolic phenomena during valvular dilations in children and 
adolescents. However, the potential for valvular debris may 
be significantly greater in older patients with heavily cal-
cified valves. Currently, our institution is engaged in the in 
vitro dilation of postmortem or surgically excised valves to 
assess embolization potential, but clearly more work is needed 
in this area. 
Another major concern surrounding mitral valvuloplasty 
is the potential problem of inducing mitral regurgitation. 
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In the previous series (9), significant mitral regurgitation 
was not observed. In our patient, mitral regurgitation in-
creased from I + to 2 + by angiographic assessment. It 
seems clear from this preliminary work, and from reports 
on closed or open mitral commissurotomy, that new or 
increased mitral regurgitation will occur in a significant 
number of patients after balloon dilation, As a result, pa-
tients with moderate to severe regurgitation should not be 
considered candidates for this procedure. 
A final concern surrounding mitral valvuloplasty is the 
potential for mitral valve restenosis. The incidence of re-
stenosis after surgical commissurotomy has been estimated 
to range from 2 to 60%, with approximately 10% of patients 
requiring reoperation in 5 years and 60% within 10 years 
(10-15). It seems likely that significant restenosis rates will 
also occur after balloon valvuloplasty. 
Conclusion. Percutaneous balloon valvuloplasty may be 
possible in selected patients with long-standing rheumatic 
mitral stenosis who are at an increased risk for surgical 
mitral valve replacement. The procedure can improve hemo-
dynamic status by increasing mitral valve orifice area, and 
may have a lower risk of morbidity and mortality than mitral 
valve surgery. Patients with moderate to severe mitral re-
gurgitation and those with left atrial thrombus should be 
excluded from consideration for the procedure. Additional 
studies are needed to further assess the safety and long-term 
efficacy of this procedure. 
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